Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-15

FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental ANDA for pramipexole dihydrochloride from Alembic Pharmaceuticals Limited. The product is a generic treatment option for Parkinson's…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole dihydrochloride (pramipexole dihydrochloride)

Snippet

SUPPL AP for PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE DIHYDROCHLORIDE)